CSL closer to gene therapy treatments for hemophilia B patients in Europe
CSL says the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)…
December 16, 2022 - 2 minutes
CSL
Gene therapy approval “game changer” in hemophilia B treatment
The approval of CSL's gene therapy Hemgenix has ushered in a new era for hemophilia…
November 24, 2022 - 7 minutes
FDA approves CSL gene therapy for hemophilia B
CSL has revealed that the U.S. Food and Drug Administration (FDA) has approved HEMGENIX (etranacogene…
November 23, 2022 - 5 minutes
Drug to treat rare kidney disease to be reviewed by EMA
The European Medicines Agency (EMA) has agreed to review a conditional marketing authorization (CMA) application…
August 22, 2022 - 3 minutes
CSL gets positive results for preventive treatment in patients with hereditary angioedema
Hereditary angioedema (HAE), a condition that causes recurrent attacks of severe swelling, could be prevented…
August 18, 2022 - 3 minutes
